Invesaro

Stocks AEVA Financial statements

Financial statements

Aeva Technologies, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Aeva Technologies, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1.384.849.274.194.319.0718.1
Cost of revenue0.822.745.838.4510.212.918.7
Gross profit0.572.13.43-4.26-5.89-3.79-0.66
Research and development15.420.574.811010310385.4
Selling and marketing0.971.684.447.047.647.166.69
General and administrative4.295.6628.431.131.833.334.8
Operating expenses20.727.8108148142155127
Operating income-20.1-25.7-104-152-148-158-128
Interest income0.520.20.373.718.937.712.74
Other non-operating income-0.02-0.021.940.94-3.790.06-0.46
Pre-tax income-19.6-25.6-102-147-149-152-145
Income tax000000.170.31
Net income to minority interests1.38
Net income-19.6-25.6-102-147-149-152-145
EBITDA-19.5-24.9-103-149-143-153-122
EPS, basic-0.85-0.90-2.54-3.39-3.29-2.85-2.55
EPS, diluted-0.85-0.90-2.54-3.39-3.29-2.85-2.55
Shares, basic (weighted)23.128.440.343.545.453.457
Shares, diluted (weighted)23.128.440.343.545.453.457

Balance sheet

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents46.624.666.867.438.528.972.3
Short-term investments037825618283.149.6
Receivables0.142.342.890.631.193.36
Inventory1.222.062.952.372.355.79
Other current assets4.979.075.475.27.7622.5
Total current assets031458335229123154
Property, plant and equipment1.615.149.7212.110.312.8
Lease right-of-use assets10.37.47.293.835.48
Intangible assets04.433.532.631.730.83
Other non-current assets0.060.860.866.138.317.03
Total assets0.1132.6479357257147180
Accounts payable2.074.395.183.65.455.89
Accrued liabilities02.614.119.062.655.7112.1
Deferred revenue0.05002.93
Total current liabilities0.085.6714.321.818.439.235.9
Lease liabilities7.464.793.770.724.21
Other non-current liabilities0.0500
Total liabilities0.085.7222.826.728.948.1166
Paid-in capital0.037.93620644688711771
Retained earnings-0-61.1-163-310-460-612-757
Other comprehensive income-0.52-3.59-0.090.05-0
Shareholders' equity48.626.945633022899.413.2
Total equity48.626.945633022899.413.2
Total liabilities and equity0.1132.6479357257147180
Shares outstanding1.2730.443.121952.454.161.6

Cash flow statement

FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-19.6-25.6-102-147-149-152-145
Depreciation and amortization0.630.81.153.274.625.485.38
Stock-based compensation2.153.8122.224.223.723.721.8
Change in receivables-0.370.23-2.2-0.552.26-0.56-2.54
Change in inventory0.6-0.87-0.84-2.550.35-1.11-3.94
Change in payables0.171.362.671.29-1.591.84-0.5
Cash from operations-16.4-21.2-82.1-110-119-107-115
Capital expenditures-0.42-0.86-3.85-7.44-6.1-5.11-4.61
Purchases of investments00-572-210-152-80-75
Sales and maturities of investments00172329233183110
Cash from investing-0.42-0.86-38911169.397.929.9
Stock issued0.040.070.910.350.240.080.13
Cash from financing360.07513-0.3720.7-0.67129
Net change in cash19.2042.20.61-28.9-9.6843.4
Free cash flow-16.8-22.1-86-117-125-112-120
Interest paid0000000
Income taxes paid000000.170.17

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $15.35 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin27.2%Gross profit / revenue.
Operating margin-610.9%Operating income / revenue.
EBITDA margin-588.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-148.9%Pre-tax income / revenue.
Net margin-150.1%Net income / revenue.
FCF margin-540.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-516.1%Cash from operations / revenue.
Return on equity (ROE)-117.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-14.2%Net income / average total assets.
R&D / revenue410.8%Research and development expense / revenue.
Stock-based pay / revenue134.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue24.0%Capital expenditures / revenue.
D&A / revenue22.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y99.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y62.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y30.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-86.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-65.8%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-13.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y21.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-20.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y40.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y6.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y9.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y14.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio7.85xCurrent assets / current liabilities.
Quick ratio6.99x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio6.85x(Cash + short-term investments) / current liabilities.
Liabilities / assets87.9%Total liabilities / total assets.
Working capital$177.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.2%(Goodwill + intangible assets) / total assets.
Tangible book value$27.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.09xRevenue / average total assets.
Fixed asset turnover1.74xRevenue / average property, plant and equipment.
Inventory turnover2.75xCost of revenue / average inventory.
Days inventory133 days365 x average inventory / cost of revenue.
Receivables turnover5.82xRevenue / average receivables.
Days sales outstanding63 days365 x average receivables / revenue.
Days payables169 days365 x average accounts payable / cost of revenue.
Cash conversion cycle26 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.33Revenue / diluted weighted shares.
FCF per share-$1.80Free cash flow / diluted weighted shares.
Operating cash flow per share-$1.72Cash from operations / diluted weighted shares.
Book value per share$0.40Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.40Tangible book value / shares outstanding.
Cash per share$2.59(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.07BShare price x shares outstanding.
Enterprise value$892.1MMarket cap + total debt - cash - short-term investments.
P/S49.5xMarket cap / revenue.
P/B38.9xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book39.4xMarket cap / tangible book value, when positive.
EV/Sales41.3xEnterprise value / revenue.
FCF yield-10.9%Free cash flow / market cap.
Earnings yield-3.0%Net income / market cap (the inverse of P/E).
What was Aeva Technologies, Inc.'s revenue in fiscal 2025?

Aeva Technologies, Inc. reported revenue of $18.1M for fiscal 2025, 99.4% higher than the year before.

Was Aeva Technologies, Inc. profitable in fiscal 2025?

No. It reported a net loss of $145.4M.

How much free cash flow did Aeva Technologies, Inc. generate in fiscal 2025?

Cash from operations of $115.1M minus capital expenditures of $4.6M left free cash flow of -$119.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Aeva Technologies, Inc.